2026 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 May 20, 2026 New Studies Show Adherence to Monthly Injectable Buprenorphine is Associated with Relapse Reduction and Lower Healthcare Utilization May 14, 2026 Indivior to Participate in Upcoming Investor Conferences May 4, 2026 Indivior Announces $175 Million Accelerated Share Repurchase April 30, 2026 Indivior Reports First Quarter 2026 Financial Results and Raises Full-Year 2026 Guidance April 24, 2026 Indivior Presents New Real-World Data at ASAM 2026 Annual Conference, Supporting Remission as a Treatment Outcome and Reinforcing the Clinical Benefits of Monthly Injectable Buprenorphine for Opioid Use Disorder April 16, 2026 Survey of Correctional Facility Staff: Monthly Opioid Treatment Shot May Help Reduce Medication Misuse April 9, 2026 Indivior to Report First Quarter 2026 Financial Results and Host Webcast on April 30th March 31, 2026 New Cost Impact Model Highlights Potential for Monthly Injectable Buprenorphine to Reduce Staffing Burdens in Correctional Facilities March 17, 2026 National Survey Finds Only 58% of U.S. Correctional Facilities Offer Medications for Opioid Use Disorder March 12, 2026 Indivior Prices Upsized $450.0 Million Convertible Senior Notes Offering
May 20, 2026 New Studies Show Adherence to Monthly Injectable Buprenorphine is Associated with Relapse Reduction and Lower Healthcare Utilization
April 30, 2026 Indivior Reports First Quarter 2026 Financial Results and Raises Full-Year 2026 Guidance
April 24, 2026 Indivior Presents New Real-World Data at ASAM 2026 Annual Conference, Supporting Remission as a Treatment Outcome and Reinforcing the Clinical Benefits of Monthly Injectable Buprenorphine for Opioid Use Disorder
April 16, 2026 Survey of Correctional Facility Staff: Monthly Opioid Treatment Shot May Help Reduce Medication Misuse
March 31, 2026 New Cost Impact Model Highlights Potential for Monthly Injectable Buprenorphine to Reduce Staffing Burdens in Correctional Facilities
March 17, 2026 National Survey Finds Only 58% of U.S. Correctional Facilities Offer Medications for Opioid Use Disorder
